Blue Owl Healthcare Opportunities

Funding rounds backed by Blue Owl Healthcare Opportunities.

Export CSV
Funding disclosed in full
$350M
Median round
$175M
Rounds in calculation
2
2 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Ambrosia Biosciences

Develops orally delivered, small molecule-based therapies for obesity and other metabolic disorders

$100MSeries BBiotechUnited States
7 participantsBlue Owl Healthcare OpportunitiesBoulder VenturesBVF PartnersDeep Track CapitalJanus Henderson InvestorsRedmileSamsara BioCapital
Mirador Therapeutics

Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases

$250MSeries BBiotechUnited States
17 participantsAdage Capital Partners L.P.ARCH Venture PartnersBlue Owl Healthcare OpportunitiesBoxer CapitalFairmountFarallon Capital ManagementFidelity Management & Research CompanyInc.InvusLogos CapitalMoore Strategic VenturesOrbiMedPoint72TCGXT. Rowe Price Investment ManagementVenrock Healthcare Capital PartnersWoodline Partners LP